市場調查報告書

抗青光眼藥的全球市場 - COVID-19影響與復甦:2020年∼2030年

Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

出版商 The Business Research Company 商品編碼 959784
出版日期 內容資訊 英文 200 Pages
商品交期: 2-3個工作天內
價格
抗青光眼藥的全球市場 - COVID-19影響與復甦:2020年∼2030年 Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
出版日期: 2020年09月09日內容資訊: 英文 200 Pages
簡介

本報告提供全球抗青光眼藥市場相關調查分析,市場特徵,市場規模與成長,市場區隔,各地區、各國明細,競爭情形,市場佔有率,趨勢與策略相關的系統性資訊。

目錄

第1章 摘要整理

第2章 抗青光眼藥市場特徵

第3章 抗青光眼藥市場規模與成長

  • 全球抗青光眼藥市場成果 (金額)
    • 推動市場要素
    • 阻礙市場要素
  • 全球抗青光眼藥市場預測 (金額)
    • 推動市場要素
    • 阻礙市場要素

第4章 抗青光眼藥市場區隔

  • 全球抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
    • Alpha促效劑
    • β- 阻斷劑
    • 前列腺素類似體
    • 並用藥
    • 其他
  • 全球抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)
    • 開放性青光眼
    • 隅角閉鎖性青光眼
    • 正常眼壓青光眼
    • 先天青光眼
    • 其他
  • 全球抗青光眼藥市場:各類型市場區隔,成果與預測 (金額)
    • 醫院處方藥
    • OTC藥

第5章 抗青光眼藥市場的各地區、各國分析

  • 全球抗青光眼藥市場:各地區,成果與預測 (金額)
  • 全球抗青光眼藥市場:各國,成果與預測 (金額)

第6章 亞太地區的抗青光眼藥市場

  • 亞太地區的抗青光眼藥市場概要
  • 亞太地區的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 亞太地區的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第7章 中國的抗青光眼藥市場

  • 中國的抗青光眼藥市場概要
  • 中國的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 中國的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第8章 印度的抗青光眼藥市場

  • 印度的抗青光眼藥市場概要
  • 印度的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 印度的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第9章 日本的抗青光眼藥市場

  • 日本的抗青光眼藥市場概要
  • 日本的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 日本的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第10章 澳洲的抗青光眼藥市場

  • 澳洲的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 澳洲的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第11章 印尼的抗青光眼藥市場

  • 印尼的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 印尼的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第12章 韓國的抗青光眼藥市場

  • 韓國的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 韓國的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第13章 西歐的抗青光眼藥市場

  • 西歐的抗青光眼藥市場概要
  • 西歐的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 西歐的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第14章 英國的抗青光眼藥市場

  • 英國的抗青光眼藥市場概要
  • 英國的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 英國的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第15章 德國的抗青光眼藥市場

  • 德國的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 德國的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第16章 法國的抗青光眼藥市場

  • 法國的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 法國的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第17章 東歐的抗青光眼藥市場

  • 東歐的抗青光眼藥市場概要
  • 東歐的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 東歐的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第18章 俄羅斯的抗青光眼藥市場

  • 俄羅斯的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 俄羅斯的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第19章 北美的抗青光眼藥市場

  • 北美的抗青光眼藥市場概要
  • 北美的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 北美的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第20章 美國的抗青光眼藥市場

  • 美國的抗青光眼藥市場概要
  • 美國的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 美國的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第21章 南美的抗青光眼藥市場

  • 南美的抗青光眼藥市場概要
  • 南美的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 南美的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第22章 巴西的抗青光眼藥市場

  • 巴西的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 巴西的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第23章 中東的抗青光眼藥市場

  • 中東的抗青光眼藥市場概要
  • 中東的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 中東的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第24章 非洲的抗青光眼藥市場

  • 非洲的抗青光眼藥市場概要
  • 非洲的抗青光眼藥市場:各產品類型市場區隔,成果與預測 (金額)
  • 非洲的抗青光眼藥市場:各病情類型市場區隔,成果與預測 (金額)

第25章 抗青光眼藥市場競爭情形和企業簡介

  • 抗青光眼藥市場競爭情形
  • 抗青光眼藥市場企業簡介
    • Aerie Pharmaceuticals, Inc
    • ALLERGAN
    • Novartis AG
    • Abbott Healthcare
    • Johnson & Johnson

第26章 抗青光眼藥市場上主要的收購與合併

第27章 抗青光眼藥市場趨勢與策略

第28章 產品平台分析

第29章 抗青光眼藥市場未來發展預測與潛力分析

第30章 附錄

目錄

Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antiglaucoma drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antiglaucoma Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Product Type: Alpha Agonist; Beta Blockers; Prostaglandin Analogs; Combined Medication; Others

2) By Disease Condition Type: Open-Angle Glaucoma; Angle-Closure Glaucoma; Normal-Tension Glaucoma; Congenital Glaucoma; Other Types Of Glaucoma

3) By Type: Hospital Prescription drugs; Over-the counter drugs

Companies Mentioned: Aerie Pharmaceuticals; ALLERGAN; Novartis AG; Abbott Healthcare; Johnson & Johnson

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Antiglaucoma Drugs Market Characteristics

3. Antiglaucoma Drugs Market Size And Growth

  • 3.1. Global Antiglaucoma Drugs Historic Market, 2015-2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Antiglaucoma Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Antiglaucoma Drugs Market Segmentation

  • 4.1. Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Alpha Agonist
    • Beta Blockers
    • Prostaglandin Analogs
    • Combined Medication
    • Others
  • 4.2. Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Open-Angle Glaucoma
    • Angle-Closure Glaucoma
    • Normal-Tension Glaucoma
    • Congenital Glaucoma
    • Other Types Of Glaucoma
  • 4.3. Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospital Prescription drugs
    • Over-the counter drugs

5. Antiglaucoma Drugs Market Regional And Country Analysis

  • 5.1. Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Antiglaucoma Drugs Market

  • 6.1. Asia-Pacific Antiglaucoma Drugs Market Overview
  • 6.2. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Antiglaucoma Drugs Market

  • 7.1. China Antiglaucoma Drugs Market Overview
  • 7.2. China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Antiglaucoma Drugs Market

  • 8.1. India Antiglaucoma Drugs Market Overview
  • 8.2. India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Antiglaucoma Drugs Market

  • 9.1. Japan Antiglaucoma Drugs Market Overview
  • 9.2. Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Antiglaucoma Drugs Market

  • 10.1. Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Antiglaucoma Drugs Market

  • 11.1. Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Antiglaucoma Drugs Market

  • 12.1. South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Antiglaucoma Drugs Market

  • 13.1. Western Europe Antiglaucoma Drugs Market Overview
  • 13.2. Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Antiglaucoma Drugs Market

  • 14.1. UK Antiglaucoma Drugs Market Overview
  • 14.2. UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Antiglaucoma Drugs Market

  • 15.1. Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Antiglaucoma Drugs Market

  • 16.4. France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Antiglaucoma Drugs Market

  • 17.1. Eastern Europe Antiglaucoma Drugs Market Overview
  • 17.2. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Antiglaucoma Drugs Market

  • 18.1. Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Antiglaucoma Drugs Market

  • 19.1. North America Antiglaucoma Drugs Market Overview
  • 19.2. North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Antiglaucoma Drugs Market

  • 20.1. USA Antiglaucoma Drugs Market Overview
  • 20.2. USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Antiglaucoma Drugs Market

  • 21.1. South America Antiglaucoma Drugs Market Overview
  • 21.2. South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Antiglaucoma Drugs Market

  • 22.1. Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Antiglaucoma Drugs Market

  • 23.1. Middle East Antiglaucoma Drugs Market Overview
  • 23.2. Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Antiglaucoma Drugs Market

  • 24.1. Africa Antiglaucoma Drugs Market Overview
  • 24.2. Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Antiglaucoma Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Antiglaucoma Drugs Market Competitive Landscape
  • 25.2. Antiglaucoma Drugs Market Company Profiles
    • 25.2.1. Aerie Pharmaceuticals, Inc
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. ALLERGAN
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Novartis AG
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Abbott Healthcare
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Johnson & Johnson
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market

27. Antiglaucoma Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Antiglaucoma Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer